83 reports

  • 8.3.4. UNLIKELY CANDIDATES FOR DELIVERY VIA AUTOINJECTORS

IT IS REPORTED TO BE MORE PREVALENT THAN DIABETES, EPILEPSY AND ASTHMA COMBINED.

  • Chronic Pain
  • Neurological Disorder
  • World
  • Forecast
  • Antares Pharma, Inc.

It is also being evaluated for the treatment of Crohn' s disease, psoriatic arthritis, and asthma.

  • Chronic Pain
  • Forecast
  • AbbVie Inc.
  • Amgen Inc.
  • F. Hoffmann-La Roche Ltd.

Physicians also avoid NSAIDs in surgeries that have no tolerance for bruising, patients with respiratory diseases such as asthma, nasal polyps and aspirin allergy.

  • Chronic Pain
  • United States
  • Egalet Corporation
  • Pfizer Inc.
  • Purdue Pharma L.P.

Rheumatoid arthritis

4546 5000 3864
  • PREVALENCE OF SELECTED CO-MORBIDITIES REPORTED IN THE INTERNATIONAL COMORA STUDY, BY REGION, 2014

In this study, patients were randomized ##:##:##:##:## to receive once-daily doses of placebo or ##mg, ##mg, ##mg, or ##mg baricitinib for ##weeks.

  • Chronic Pain
  • Japan
  • United States
  • Pfizer Inc.
  • Roche Group
  • 18.1 INTRODUCTION
  • SWITZERLAND HIP RECONSTRUCTION DEVICES MARKET, BY SURGERY TYPE,

IN THE U. K., ## IN ## WOMEN AND ## IN ## MEN SUFFER FRACTURES AFTER THE AGE OF ##.

  • Chronic Pain
  • Forecast
  • Market Size
  • Smith & Nephew Plc
  • Zimmer Biomet Holdings, Inc.
  • 18.1 INTRODUCTION
  • SWITZERLAND HIP RECONSTRUCTION DEVICES MARKET, BY SURGERY TYPE,

IN THE U. K., ## IN ## WOMEN AND ## IN ## MEN SUFFER FRACTURES AFTER THE AGE OF ##.

  • Chronic Pain
  • South America
  • Forecast
  • Market Size
  • Zimmer Biomet Holdings, Inc.
  • CANADA: AUTOINJECTORS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • US: AUTOINJECTORS MARKET, BY END USER, 2016-2023 (USD BILLION)

Glucagon-like peptide-##, commonly known as GLP-##, is a hormone produced by the proglucagon gene in the L-cells of the gut.

  • Chronic Pain
  • Drug Delivery
  • Injectable Delivery
  • Therapy
  • Amgen Inc.

IT AFFECTS ## IN ##, ## TO ## IN ##, ## BIRTHS.

  • Chronic Pain
  • Clinical Trial
  • Hospital
  • Nucleic Acid
  • GlobalData's company
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY INDICATION, H2 2017
  • PIPELINE BY PARADIGM BIOPHARMACEUTICALS LTD, H2 2017

It is in preclinical stage for the treatment of allergic asthma and heart failure.

  • Arthritis
  • Chronic Pain
  • Clinical Trial
  • Therapy
  • Galapagos NV
  • Alphavirus Infections
  • PIPELINE BY PARADIGM BIOPHARMACEUTICALS LTD, H1 2018

Also presented today are the results of a Phase ## study conducted in healthy subjects.

  • Chronic Pain
  • Australia
  • United States
  • World
  • Product Initiative
  • Alphavirus Infections
  • Pipeline by Paradigm Biopharmaceuticals Ltd, H1 2018

It is in preclinical stage for the treatment of allergic asthma and heart failure.

  • Chronic Pain
  • Clinical Trial
  • Therapy
  • World
  • Product Initiative
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY INDICATIONS, H2 2017
  • PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H2 2017

The molecules developed by companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are ##, ##, ##, ## and ## respectively.

  • Arthritis
  • Cardiovascular Drug
  • Chronic Pain
  • Therapy
  • Can-Fite BioPharma Ltd.

It develops inhalation products, to help patients suffering from airways diseases such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, pulmonary fibrosis and other diseases.

  • Chronic Pain
  • Hospital
  • Pharmaceutical
  • Therapy
  • Incyte Corporation
  • REJOIN - DRUG PROFILE
  • OSTEOARTHRITIS - DORMANT PROJECTS, H1 2018 (CONTD..4), H1 2018

It is in preclinical stage for the treatment of allergic asthma and heart failure.

  • Arthritis
  • Cell Therapy
  • Chronic Pain
  • Therapy
  • Amgen Inc.
  • DORMANT PRODUCTS, H1 2018 (CONTD..1), H1 2018
  • DORMANT PRODUCTS, H1 2018 (CONTD..3), H1 2018

Neurim offers treatments for other therapeutic areas that include Parkinson' s disease, and asthma or chronic obstructive pulmonary disease.

  • Arthritis
  • Chronic Pain
  • Therapy
  • United States
  • Flex Pharma, Inc.

The molecules developed by Companies in Phase III, Phase II and Phase I stages are ##, ## and ## respectively.

  • Chronic Pain
  • Musculoskeletal Disorder
  • Pharmaceutical
  • Therapy
  • United States
  • Number of Products under Development by Indication, H2 2017
  • Pipeline by Paradigm Biopharmaceuticals Ltd, H2 2017

It is in preclinical stage for the treatment of allergic asthma and heart failure.

  • Chronic Pain
  • Clinical Trial
  • Therapy
  • Australia
  • Product Initiative

NO has a solid place in asthma management.

  • Drug Test
  • United States
  • Alere Inc.
  • Dräger Group
  • Thermo Fisher Scientific, Inc.
  • TOREFORANT TARTRATE

It was under development for the treatment of asthma.

  • Chronic Pain
  • Lymphoma
  • Monoclonal Antibody
  • Therapy
  • United States
  • DORMANT PRODUCTS, H2 2017 (CONTD..4), H2 2017
  • PIPELINE BY PFIZER INC, H2 2017

The small molecules were also under development for asthma and rheumatoid arthritis.

  • Chronic Pain
  • Hospital
  • Therapy
  • United States
  • Product Initiative
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY INDICATIONS, H2 2017
  • PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H2 2017 (CONTD..1), H2 2017

It develops inhalation products, to help patients suffering from airways diseases such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, pulmonary fibrosis and other diseases.

  • Chronic Pain
  • Therapy
  • United States
  • Product Initiative
  • Pfizer Inc.
  • PIPELINE BY PFIZER INC, H1 2018
  • PIPELINE BY REGENERON PHARMACEUTICALS INC, H1 2018

Regeneron also has various product candidates under clinical development for treating asthma, pain, cancer, atopic dermatitis and infectious diseases.

  • Chronic Pain
  • United States
  • World
  • Product Initiative
  • Pfizer Inc.
  • R&D Progress
  • R&D Progress

The primary outcome measure of the study is to assess the improvement in the severity of asthma as measured by change in the asthma control questionnaire (ACQ) score.

  • Autoimmune Disease
  • Chronic Pain
  • Monoclonal Antibody
  • Therapy
  • United States
  • INNOVIMMUNE BIOTHERAPEUTICS INC
  • INV-88 - DRUG PROFILE

Secondary endpoints include asthma exacerbation rate and the degree of asthma symptom control.

  • Cell Therapy
  • Chronic Pain
  • Neurological Disorder
  • Pathology
  • Anavex Life Sciences Corp.
  • DORMANT PRODUCTS, H1 2018 (CONTD..2), H1 2018
  • Tyrosine Protein Kinase JAK3 (Janus Kinase 3 or Leukocyte Janus Kinase or JAK3 or EC 2.7.10.2) - Dormant Products

Encore presentation from the WCOG at ACG2017 ##.

  • Chronic Pain
  • Therapy
  • United States
  • Product Initiative
  • Pfizer Inc.
  • R&D Progress
  • DALAZATIDE - DRUG PROFILE

AbbVie is also evaluating the potential of this biologic in Crohn' s disease, psoriatic arthritis, and asthma.

  • Autoimmune Disease
  • Biosimilar
  • Chronic Pain
  • United States
  • Product Initiative
  • Clinical Trial profile. 274 Trial Title
  • Clinical Trial Profile Snapshots

Patients were randomized to one of three treatment groups (##:##:##) and received either a single IA injection of ZILRETTA (## mg), normal saline-placebo or triamcinolone acetonide in crystalline suspension (TAcs) (## mg).

  • Chronic Pain
  • Clinical Trial
  • Musculoskeletal Disorder
  • Opioid
  • Pain Therapeutics
  • PIPELINE BY REGENERON PHARMACEUTICALS INC, H2 2017

Regeneron is also developing various product candidates in clinical development for treating asthma, pain, cancer, atopic dermatitis and infectious diseases.

  • Chronic Pain
  • United States
  • World
  • Product Initiative
  • Pfizer Inc.

ABBVIE IS ALSO EVALUATING THE POTENTIAL OF THIS BIOLOGIC IN CROHN' S DISEASE, PSORIATIC ARTHRITIS, AND ASTHMA.

  • Autoimmune Disease
  • Chronic Pain
  • United States
  • Company
  • Company Operations
  • SYNTHETIC PEPTIDES FOR ALLERGIC ASTHMA AND RHEUMATOID ARTHRITIS - DRUG PROFILE
  • SODIUM HYPOCHLORITE - DRUG PROFILE

Rheumatoid Arthritis - Pipeline Review, H2 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Rheumatoid Arthritis - Pipeline Review, H2 2017, provides an overview of the Rheumatoid Arthritis (Immunology) pipeline landscape. Rheumatoid arthritis...

  • Arthritis
  • Chronic Pain
  • Pathology
  • Therapy
  • Pfizer Inc.